Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety, Tolerability, and Pharmacokinetics of LY110140 in Healthy Japanese Males
jRCT2080221755Phase 1
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fluoxetine (6 arms), sponsored by Eli Lilly and Company. Primary endpoints: Safety and tolerability of LY110140 and Pharmacokinetics of LY110140.
02
Drugs
fluoxetine
Beyond the preview
Go deeper on jRCT2080221755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221755.